These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 15293354)
1. Elimination of linezolid by an in vitro extracorporeal circuit model. Schroeder TH; Hansen M; Stephan M; Hoffmann E; Unertl K; Krueger WA Int J Artif Organs; 2004 Jun; 27(6):473-9. PubMed ID: 15293354 [TBL] [Abstract][Full Text] [Related]
2. Elimination of meropenem by continuous hemo(dia) filtration: an in vitro one-compartment model. Schroeder TH; Krueger WA; Hansen M; Hoffmann E; Dieterich HJ; Unertl K Int J Artif Organs; 1999 May; 22(5):307-12. PubMed ID: 10467928 [TBL] [Abstract][Full Text] [Related]
3. Elimination of teicoplanin by adsorption to the filter membrane during haemodiafiltration: screening experiments for linezolid, teicoplanin and vancomycin followed by in vitro haemodiafiltration models for teicoplanin. Shiraishi Y; Okajima M; Sai Y; Miyamoto K; Inaba H Anaesth Intensive Care; 2012 May; 40(3):442-9. PubMed ID: 22577909 [TBL] [Abstract][Full Text] [Related]
4. Linezolid clearance during continuous venovenous hemodiafiltration: a case report. Kraft MD; Pasko DA; DePestel DD; Ellis JJ; Peloquin CA; Mueller BA Pharmacotherapy; 2003 Aug; 23(8):1071-5. PubMed ID: 12921253 [TBL] [Abstract][Full Text] [Related]
5. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure. Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Sagripanti S; Manini P; Andreoli R; Cabassi A Crit Care Med; 2004 Dec; 32(12):2437-42. PubMed ID: 15599148 [TBL] [Abstract][Full Text] [Related]
6. Clearance of linezolid via continuous venovenous hemodiafiltration. Mauro LS; Peloquin CA; Schmude K; Assaly R; Malhotra D Am J Kidney Dis; 2006 Jun; 47(6):e83-6. PubMed ID: 16731287 [TBL] [Abstract][Full Text] [Related]
7. The adsorption of vancomycin by polyacrylonitrile, polyamide, and polysulfone hemofilters. Tian Q; Gomersall CD; Leung PP; Choi GY; Joynt GM; Tan PE; Wong AS Artif Organs; 2008 Jan; 32(1):81-4. PubMed ID: 18181809 [TBL] [Abstract][Full Text] [Related]
9. Multiple-dose pharmacokinetics of linezolid during continuous venovenous haemofiltration. Meyer B; Kornek GV; Nikfardjam M; Karth GD; Heinz G; Locker GJ; Jaeger W; Thalhammer F J Antimicrob Chemother; 2005 Jul; 56(1):172-9. PubMed ID: 15905303 [TBL] [Abstract][Full Text] [Related]
10. Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes. Bouman CS; van Olden RW; Stoutenbeek CP Blood Purif; 1998; 16(5):261-8. PubMed ID: 9917534 [TBL] [Abstract][Full Text] [Related]
11. Linezolid: the first oxazolidinone antimicrobial. Moellering RC Ann Intern Med; 2003 Jan; 138(2):135-42. PubMed ID: 12529096 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of linezolid in septic patients with and without extended dialysis. Swoboda S; Ober MC; Lichtenstern C; Saleh S; Schwenger V; Sonntag HG; Haefeli WE; Hempel G; Hoppe-Tichy T; Weigand MA Eur J Clin Pharmacol; 2010 Mar; 66(3):291-8. PubMed ID: 20013257 [TBL] [Abstract][Full Text] [Related]
13. Single dose pharmacokinetics of linezolid in infants and children. Kearns GL; Abdel-Rahman SM; Blumer JL; Reed MD; James LP; Jacobs RF; Bradley JA; Welshman IR; Jungbluth GL; Stalker DJ; Pediatr Infect Dis J; 2000 Dec; 19(12):1178-84. PubMed ID: 11144380 [TBL] [Abstract][Full Text] [Related]
14. In vitro Evaluation of Linezolid and Doripenem Clearance with Different Hemofilters. Hiraiwa T; Moriyama K; Matsumoto K; Shimomura Y; Kato Y; Yamashita C; Hara Y; Kawaji T; Kurimoto Y; Nakamura T; Kuriyama N; Shibata J; Komura H; Morita K; Nishida O Blood Purif; 2020; 49(3):295-301. PubMed ID: 31995801 [TBL] [Abstract][Full Text] [Related]